Products

ASSURE Wearable ECG
Kestra Medical Technologies
Cardiology AI
Kestra Medical Technologies offers the ASSURE Wearable ECG, a non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients.

See all 1 product →

About Kestra Medical Technologies

Kestra Medical Technologies is a commercial-stage wearable medical device and digital healthcare company dedicated to improving outcomes in cardiovascular disease. The company focuses on connected monitoring, therapeutic intervention, and data-driven clinical insights. Their flagship product is the ASSURE Wearable Cardioverter Defibrillator (WCD) system, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable recovery periods. The ASSURE system continuously monitors patient heart activity and delivers life-saving defibrillation therapy when needed.

For physicians, Kestra’s Cardiac Recovery System platform offers a modern approach to SCA protection. It includes the ASSURE WCD, the ASSURE patient application, and the Kestra CareStation® remote patient data platform, all working together as a digital healthcare system. The ASSURE WCD is designed for patient comfort and clinical performance, available in multiple sizes and styles to promote patient compliance. The system aims to reduce false alarms and provides actionable insights to help care teams detect meaningful cardiac events. Kestra also offers connected services like Heart Alert™ for provider notification of potential cardiac events and ASSURE Assist® service, which connects patients to emergency services after a shock, extending the reach of care teams. Kestra’s strategy emphasizes product design, wearability, patient adherence, and clinician workflow.

Focus Areas

Wearable cardiac therapeutic devices Remote patient monitoring and telehealth Arrhythmia detection and ECG analytics Mobile health applications Sudden Cardiac Arrest (SCA) prevention Cardiovascular disease management

Business Intelligence

TechnologyCloud-hosted platform for remote patient data, Mobile health application, Multi-channel ECG acquisition, Defibrillation therapy hardware, ECG signal processing and artifact reduction, Arrhythmia detection algorithms, Textile-integrated biosensors, Cloud-based analytics and dashboards, Mobile health app with encrypted transmission, Emergency services dispatch integration

What Physicians Need to Know

Specialization
Kestra Medical Technologies is a wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease. They specialize in diagnostic monitoring and therapeutic technologies that are intuitive, intelligent, and connected. Their core offering is the ASSURE® Wearable Cardioverter Defibrillator (WCD) system, which provides continuous cardiac monitoring, defibrillation therapy, and connected digital workflow tools for patients and clinicians.
Key Differentiators
Kestra's key differentiators include their focus on product design, wearability, patient adherence, and clinician workflow. Their ASSURE WCD system aims to improve patient comfort and compliance while reducing false alarm rates through 4-channel ECG technology. They have also demonstrated a 100% successful conversion rate for ventricular arrhythmia events in a large prospective real-world study, with high median daily wear time (over 23 hours) and a low false alarm rate (only 6%). Kestra also emphasizes 'Empathy Powered Design' in their product development.
Technology Stack (Healthcare AI Tools)
While specific proprietary AI tools are not fully detailed, Kestra's offerings involve advanced sensors and algorithms for arrhythmia detection. They also utilize digital health solutions and connected workflow tools. For their broader healthcare AI tools and data orchestration, Kestra offers an open-source, HIPAA-compliant workflow automation engine. This engine can orchestrate medical AI pipelines, genomics workflows, and pharmacy supply chains, ensuring PHI stays within the perimeter. It supports Kubernetes, OpenShift, and GPU workers, with a PostgreSQL backend. They also integrate with tools like Airbyte for data ingestion and extraction.
Strategic Collaborations
Kestra has a strategic collaboration with Biobeat Technologies to expand diagnostic insight for wearable defibrillator patients during cardiac recovery. This includes integrating Biobeat's clinically validated, FDA-cleared cuffless, patch-worn ambulatory blood pressure monitoring (ABPM) device into Kestra's product portfolio.
Physician Tip

For physicians, Kestra Medical Technologies offers the ASSURE® Wearable Cardioverter Defibrillator (WCD) system, which provides continuous cardiac monitoring and therapeutic intervention for patients at risk of sudden cardiac arrest. The system is designed with a focus on patient comfort and adherence, aiming to reduce false alarms and provide reliable data. The collaboration with Biobeat Technologies will provide better visibility into blood pressures during cardiac recovery, which can significantly support clinical decision-making, especially for hypertensive patients. Kestra's digital workflow tools are also designed to streamline clinician processes. Their healthcare AI tools can also assist in orchestrating medical AI pipelines and managing HIPAA-compliant data operations, keeping PHI within your perimeter.

Kestra's open-source workflow automation engine is designed for integration within the modern data stack. It offers extensive integrations with popular data tools, including Airbyte for efficient ETL processes and data ingestion. The system is built to be self-hosted, VPC, or fully air-gapped, with segment control plane and workers across restricted zones to ensure PHI never leaves your perimeter. It also supports various worker environments like Kubernetes, OpenShift, and GPU workers, and integrates with SIEM systems for audit logs.

Products by Kestra Medical Technologies

1 product in the directory

ASSURE Wearable ECG
Kestra Medical Technologies
Cardiology AI
Kestra Medical Technologies offers the ASSURE Wearable ECG, a non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients.

What the Web Says

Kestra Medical Technologies receives overwhelmingly positive reviews as an employer, with employees praising its culture, management, and commitment to patients. The company's main product, the ASSURE Wearable Cardioverter Defibrillator (WCD), is also viewed positively for its life-saving capabilities and patient-first approach. While there are strong positive sentiments, some challenges are noted regarding inventory supply and competition in the market.

Overall: Positive

Strengths

  • Great company culture and people-first organization.
  • Solid and committed management.
  • Product (ASSURE WCD) is innovative, saves lives, and provides comfort and reliability to patients.
  • Strong focus on innovation and an inclusive culture.
  • Good work-life balance and benefits.
  • Opportunity for growth in a rapidly expanding company.

Limitations

  • Inventory supply can be a challenge.
  • Competition from established players like Zoll.
  • Some physicians may not prioritize design over existing solutions.
  • As a startup, there are ongoing changes to meet demands, requiring adaptability from employees.
  • Company is not yet profitable, with negative EPS and ROE.

Based on reviews from: Indeed, Top Workplaces, Reddit, DirectorsTalk Interviews, G2

Last updated: 2026-10-22

Videos

News, demos, and interviews about Kestra Medical Technologies.

Loading videos...

Videos load interactively. If none appear, search YouTube for Kestra Medical Technologies →

View all on YouTube

Press & Coverage

Kestra Medical Technologies
Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery
Kestra Medical Technologies announced a strategic collaboration with Biobeat Technologies to integrate Biobeat's cuffless ambulatory blood pressure monitoring (ABPM) technology into Kestra's product portfolio, aiming to expand diagnostic insights for patients using the ASSURE® Wearable Cardioverter Defibrillator (WCD).
2026-01
Kestra Medical Technologies
Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing
Kestra Medical Technologies secured a five-year term loan facility with funds managed by Pharmakon Advisors, LP, providing up to $200 million in non-dilutive financing to support its operations and growth.
2026-07
Kestra Medical Technologies
Kestra Medical Technologies to Showcase Cardiac Recovery System® Platform at Heart Rhythm 2026
Kestra Medical Technologies announced its participation in Heart Rhythm 2026 to showcase its Cardiac Recovery System® platform, highlighting its integrated approach to managing sudden cardiac arrest risk and a new FDA-approved ASSURE WCD algorithm update.
2026-04
MedAxiom
MedAxiom Announces Industry Partnership with Kestra Medical Technologies to Enhance Sudden Cardiac Arrest Risk Management
MedAxiom announced a new industry partnership with Kestra Medical Technologies to connect the MedAxiom community with Kestra's Cardiac Recovery System® platform, aiming to provide clinicians with new tools for managing sudden cardiac arrest risk.
2025-10
Business Wire
Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round
Kestra Medical Technologies announced an oversubscribed $196 million funding round co-led by Andera Partners, Ally Bridge Group, Longitude Capital, and Omega Funds, to support the expansion of its commercial organization and advance its Wearable Cardioverter Defibrillator (WCD).
2024-07
GlobeNewswire
Kestra Medical Technologies Earns Five-Star Rating on Newsweek's List of America's Greatest Mid-Market Companies
Kestra Medical Technologies received a five-star rating on Newsweek's list of America's Greatest Mid-Market Companies, recognizing its performance and growth.
2026-10
GlobeNewswire
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
Kestra Medical Technologies reported its financial results for the first quarter of fiscal year 2027, with revenue reaching $31 million, a 60% increase year-over-year, though the company reported a larger-than-expected loss per share.
2026-09
Kestra Medical Technologies
Ernst & Young LLP Names Brian Webster of Kestra Medical Technologies as an Entrepreneur Of The Year® 2025 Mountain West Award Finalist
Brian Webster, President and CEO of Kestra Medical Technologies, was named a finalist for the Entrepreneur Of The Year® 2025 Mountain West Award, recognizing his entrepreneurial spirit and impact in transforming healthcare.
2025-05

Frequently Asked Questions

Kestra Medical Technologies offers the ASSURE Wearable Cardioverter Defibrillator (WCD) System, which provides continuous heart rhythm monitoring and automatic defibrillation. The system integrates with the Kestra CareStation, a remote patient data platform that offers efficient tools for managing cardiac patient care and provides clear patient insights. Additionally, Kestra is integrating Biobeat's technology to provide continuous, cuffless ambulatory blood pressure monitoring (ABPM) data for ASSURE WCD patients, which can aid in clinical decision-making, especially for hypertensive patients during cardiac recovery.
Kestra Medical Technologies is a medical device company that adheres to medical device regulatory compliance, including ISO 13485 and FDA PMA. Their workflow automation solutions for healthcare are designed to be HIPAA-compliant, ensuring Protected Health Information (PHI) stays within the healthcare provider's perimeter. They also focus on medical device cybersecurity and vulnerability management.
While specific pricing for healthcare organizations is not publicly detailed, Kestra offers an open-source engine for healthcare workflow automation, with enterprise plans available for organizations requiring high-security standards and dedicated support. Pricing for their wearable devices would typically involve considerations for the device itself, ongoing monitoring, and data platform access, often handled through payer reimbursement.
Kestra Medical Technologies provides patient training and clinical support services. They offer a dedicated 24/7 toll-free helpline for ASSURE support for both patients and healthcare providers. Additionally, they provide essential clinical resources, including abstracts, publications, and peer-reviewed data, for continuing education and clinical implementation of the ASSURE WCD.
Kestra Medical Technologies has established strategic partnerships to enhance its offerings. They have a collaboration with Biobeat Technologies to integrate cuffless ambulatory blood pressure monitoring into their ASSURE WCD system. Kestra also announced an industry partnership with MedAxiom to enhance sudden cardiac arrest risk management.
Kestra Medical Technologies is a publicly traded company (NASDAQ: KMTS) with a market capitalization of $1.75 billion as of October 2026. The company has shown significant revenue growth, with a 59.9% surge, and has garnered positive analyst ratings. While currently not profitable, with ongoing financial hurdles, investor sentiment remains optimistic due to its innovative products and growth trajectory. Kestra was also recognized with a five-star rating on Newsweek's list of America's Greatest Mid-Market Companies in 2026.

Investors

Who's funded Kestra Medical Technologies.

Related Companies

TimeDoc Health is a healthcare technology and services company that provides virtual care management solutions, primarily focusing on chronic care management (CCM), remote patient monitoring (RPM), and behavioral health integration (BHI). Their platform and services are designed to help healthcare organizations, including primary care providers, health systems, FQHCs (Federally Qualified Health Centers), and Medicare Advantage […]

Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]

CureCompanion is a healthcare technology company that specializes in virtual care solutions, offering an integrated platform of hardware and software for telemedicine. Their technology goes beyond basic video conferencing, enabling healthcare providers to conduct comprehensive virtual examinations. This includes the ability to examine skin, eyes, ears, and throat using HD cameras, listen to heart and […]

Caption Health, formerly known as Bay Labs and now part of GE HealthCare, is a pioneering medical artificial intelligence (AI) company dedicated to expanding access to high-quality ultrasound examinations. The company’s core offering is the Caption AI platform, which utilizes AI to guide healthcare providers, including those without extensive specialized training, in acquiring and interpreting […]

Anumana is an AI-driven health technology company dedicated to transforming cardiovascular care. Co-founded by nference and Mayo Clinic, Anumana develops software-as-a-medical-device (SaMD) solutions that leverage multimodal AI to support early detection, clinical decision-making, and intraoperative guidance across the continuum of care. The company’s portfolio includes FDA-cleared ECG-based algorithms, generative imaging applications, and real-time procedural support […]

Keya Medical Technology Co. is an international medical technology company specializing in deep learning-based AI solutions for non-invasive disease diagnosis and treatment. The company, founded in 2016, develops AI-enabled diagnostic devices that aim to enhance efficiency, accuracy, and precision in healthcare across various specialties, including cardiology, neurology, pulmonology, pathology, and surgery. [2, 4, 8, 14] […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.